Zobrazeno 1 - 10
of 508
pro vyhledávání: '"Tumor target"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/ae3d624b063a41e1a25c3eee1339c2f2
Publikováno v:
Cancer Medicine, Vol 13, Iss 10, Pp n/a-n/a (2024)
Abstract Background and Purpose Respiratory movement has an important impact on the radiotherapy for lung tumor. Respiratory gating technology is helpful to improve the accuracy of target delineation. This study investigated the value of prospective
Externí odkaz:
https://doaj.org/article/4b8d8fe3555048fabc40c03d0de67713
Autor:
Jiewen Chen, Qingji Xu, Dan Liu, Xun Li, Mingyan Guo, Xuehui Chen, Jianyou Liao, Rong Lei, Wende Li, Hongyan Huang, Phei Er Saw, Erwei Song, Xiyun Yan, Yan Nie
Publikováno v:
Cancer Communications, Vol 43, Iss 11, Pp 1244-1266 (2023)
Abstract Background As a rapid‐progressing tumor, breast malignant phyllodes tumors (PTs) are challenged by the lack of effective therapeutic strategies and suitable prognostic markers. This study aimed to clarify the role and mechanism of CD146 on
Externí odkaz:
https://doaj.org/article/76cb4f732506496bb20cd5f17d7d2c0e
Publikováno v:
BMC Research Notes, Vol 16, Iss 1, Pp 1-6 (2023)
Abstract Objective The discovery and characterization of tumor associated antigens is increasingly important to advance the field of immuno-oncology. In this regard, labyrinthin has been implicated as a neoantigen found on the cell surface of adenoca
Externí odkaz:
https://doaj.org/article/7a5e6d2c90f04a4b9ccd7548bb911185
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Externí odkaz:
https://doaj.org/article/dd3fc7c2e5514120be6a3be2ad803d85
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 11, Iss 4, Pp 95-107 (2022)
Introduction. For the last decade, nanotechnology has been studied extensively in the pharmaceutical field. Among all the nanotechnology formulation areas, nanostructured lipid carrier is enormously researched by formulation scientists as it is one o
Externí odkaz:
https://doaj.org/article/872497cf97c24ee5b53f4d0d4862ef4a
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveABI Family Member 3 Binding Protein (ABI3BP) is an extracellular matrix protein that affects the carcinogenesis of lung and esophageal cancer. However, the relevance of ABI3BP in different forms of cancer is uncertain.MethodsABI3BP expressio
Externí odkaz:
https://doaj.org/article/dac684a1d84b4b3bad6095fa20a50b65
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionOsteosarcoma tumors are the most common malignant bone tumors in children and adolescents. Their treatment usually requires surgical removal of all detectable cancerous tissue and multidrug chemotherapy; however, the prognosis for patient
Externí odkaz:
https://doaj.org/article/7f52c32f18e64c19a13ca39ce56c98a9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Valli De Re, Ombretta Repetto, Lara Mussolin, Giulia Brisotto, Caterina Elia, Egesta Lopci, Emanuele S. G. d’Amore, Roberta Burnelli, Maurizio Mascarin
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Currently-available therapies for newly-diagnosed pediatric and adolescent patients with Hodgkin lymphoma result in >95% survival at 5 years. Long-term survivors may suffer from long-term treatment-related side effects, however, so the past 20 years
Externí odkaz:
https://doaj.org/article/25b8bf36454644cabb8584bbed9308eb